검색어 : 통합검색[Whitworth Laura]
총 99건 중 99건 출력
, 9/10 페이지
-
81
- Combined 70- and 80-gene signatures identify tumors with genomically luminal biology responsive to neoadjuvant endocrine therapy and are prognostic of 5-year outcome in early-stage breast cancer
- Pellicane, James V.; Beitsch, Peter D.; Rock, David T.; Budway, Raye J.; Dul, Carrie L.; Kelemen, Pond R.; Ashikari, Andrew Y.; Baron, Paul L.; Weinstein, Paul D.; Mislowsky, Angela; Lee, Laura A.; Beatty, Jennifer; Murray, Mary K.; Dupree, Beth B.; Finn, Christine; Corcoran, Kate; Wang, Shiyu; Menicucci, Andrea R.; Yoder, Erin B.; Blumencranz, Lisa E.; Dauer, Patricia; Audeh, William; Whitworth, Pat W.; ; (Surgical oncology, v.45, 2022, pp.101885)
-
82
- Abstract PD9-08: ImPrint immune signature in 10,000 early-stage breast cancer patients from the real-world FLEX database
- Brufsky, Adam M.; Kuilman, Midas; Mukhtar, Rita; Wolf, Denise M.; Yau, Christina; O’Shaughnessy, Joyce; Graham, Cathy; Gadi, Vijayakrishna K.; Whitworth, Pat; Hindenburg, Alexander; Grady, Ian; Srkalovic, Gordon; Hoskins, Kent; Dhakal, Ajay; Ma, Cynthia; Hunter, Natasha; Crozier, Jennifer; Mavromatis, Blanche; Mittempergher, Lorenza; Finn, Christine; Modh, Shraddha; Yoder, Erin B.; Dauer, Patricia; Menicucci, Andrea; van der Baan, Bas; Audeh, William; Esserman, Laura J.; 1UPMC Hillman Cancer Center, University of Pittsburgh Medical Center; 2Agendia NV; 3University of California, San Francisco; 4University of California, San Francisco; 5University of California, San Francisco and Buck Institute for Research on Aging, Novato, California; 6Baylor University Medical Center, Texas Oncology, US Oncology, Dallas, TX; 7Emory University; 8University of Illinois; 9University of Tennessee, Nashville, Tennessee; 10NYU Langone; 11North Valley Breast Clinic; 12Sparrow Hospital System; 13University of Illinois Chicago; 14University of Rochester Medical Center, Rochester, New York; 15Washington University in St. Louis, St. Louis, MO; 16Seattle Cancer Care Alliance, Seattle, WA; 17Baptist MD Anderson Cancer Center, Jacksonville, FL; 18UPMC Western Maryland; 19Agendia NV, Amsterdam, Noord-Holland, Netherlands; 20Agendia Inc; 21Agendia Inc; 22Agendia, Irvine, California; 23Agendia Inc; 24Agendia Inc; 25Agendia; 26Agendia Inc; 27University of Cal; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.PD9-08-PD9-08)
-
83
- Genomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy
- Whitworth, Pat W.; Beitsch, Peter D.; Murray, Mary K.; Richards, Paul D.; Mislowsky, Angela; Dul, Carrie L.; Pellicane, James V.; Baron, Paul L.; Rahman, Rakhshanda Layeequr; Lee, Laura A.; Dupree, Beth B.; Kelemen, Pond R.; Ashikari, Andrew Y.; Budway, Raye J.; Lopez-Penalver, Cristina; Dooley, William; Wang, Shiyu; Dauer, Patricia; Menicucci, Andrea R.; Yoder, Erin B.; Finn, Christine; Blumencranz, Lisa E.; Audeh, William; Nashville Breast Center, Nashville, TN; Targeted Medical Education, Cupertino, CA; Akron General Medical Center, Akron, OH; Blue Ridge Cancer Center, Roanoke, VA; Tidelands Health, Coastal Carolina Breast Center, Murrells Inlet, SC; Ascension St John Hospital Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI; Bon Secours Virginia Breast Center, Midlothian, VA; Breast and Melanoma Specialist of Charleston, Charleston, SC; Texas Tech University, Lubbock, TX; Comprehensive Cancer Center, Palm Springs, CA; St Mary Medical/Alliance Cancer Specialists, Langhorne, PA; Ashikari Breast Center, Sleepy Hollow, NY; Ashikari Breast Center, Sleepy Hollow, NY; St Clair Hospital, Pittsburgh, PA; Baptist Health South Florida, Miami, FL; Breast Institute, University of Oklahoma Health Sciences, Oklahoma City, OK; Agendia Inc, Irvine, CA; Agendia Inc, Irvine, CA; Agendia Inc, Irvine, CA; Agendia Inc, Irvine, CA; Agendia Inc, Irvine, CA; Agendia Inc, Irvine, CA; Agen; (Jco precision oncology, v.6, 2022, pp.e2200197)
-
84
- Confounding factors in targeted degradation of short-lived proteins
- Vetma Vesna; Casarez-Perez Laura; Eliaš Ján; Stingu Andrea; Kombara Anju; Gmaschitz Teresa; Braun Nina; Ciftci Tuncay; Dahmann Georg; Diers Emelyne; Gerstberger Thomas; Greb Peter; Kidd Giorgia; Kofink Christiane; Puoti Ilaria; Spiteri Valentina; Trainor Nicole; Westermaier Yvonne; Whitworth Claire; Ciulli Alessio; Farnaby William; McAulay Kirsten; Frost Aileen B.; Chessum Nicola; Koegl Manfred; ; (, v., 2024, )
-
85
- A cell-penetrant peptide blocking <i>C9ORF72</i> -repeat RNA nuclear export reduces the neurotoxic effects of dipeptide repeat proteins
- Castelli, Lydia M.; Lin, Ya-Hui; Sanchez-Martinez, Alvaro; Gü l, Aytaç ; Mohd Imran, Kamallia; Higginbottom, Adrian; Upadhyay, Santosh Kumar; Má rkus, Nó ra M.; Rua Martins, Raquel; Cooper-Knock, Johnathan; Montmasson, Claire; Cohen, Rebecca; Walton, Amy; Bauer, Claudia S.; De Vos, Kurt J.; Mead, Richard J.; Azzouz, Mimoun; Dominguez, Cyril; Ferraiuolo, Laura; Shaw, Pamela J.; Whitworth, Alexander J.; Hautbergue, Guillaume M.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.; MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Hills Road, Cambridge CB2 0XY, UK.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, 385 Glossop Road, Sheffield S10 2HQ, UK.; Leicester Institute of Structural and Chemical Biology and Department of Molecular and Cell Biology, University of Leicester, Leicester LE1 7RH, UK.; Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffi; (Science translational medicine, v.15, 2023, pp.eabo3823)
-
86
- Ki67 Proliferation Index as a Tool for Chemotherapy Decisions During and After Neoadjuvant Aromatase Inhibitor Treatment of Breast Cancer: Results From the American College of Surgeons Oncology Group Z1031 Trial (Alliance)
- Ellis, Matthew J.; Suman, Vera J.; Hoog, Jeremy; Goncalves, Rodrigo; Sanati, Souzan; Creighton, Chad J.; DeSchryver, Katherine; Crouch, Erika; Brink, Amy; Watson, Mark; Luo, Jingqin; Tao, Yu; Barnes, Michael; Dowsett, Mitchell; Budd, G. Thomas; Winer, Eric; Silverman, Paula; Esserman, Laura; Carey, Lisa; Ma, Cynthia X.; Unzeitig, Gary; Pluard, Timothy; Whitworth, Pat; Babiera, Gildy; Guenther, J. Michael; Dayao, Zoneddy; Ota, David; Leitch, Marilyn; Olson Jr, John A.; Allred, D. Craig; Hunt, Kelly; Baylor College of Medicine; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.35, 2017, pp.1061-1069)
-
87
- ASO Visual Abstract: Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
- Whitworth, Pat; Beitsch, Peter D.; Pellicane, James V.; Baron, Paul L.; Lee, Laura A.; Dul, Carrie L.; Nash III, Charles H.; Murray, Mary K.; Richards, Paul D.; Gittleman, Mark; Budway, Raye; Layeequr Rahman, Rakhshanda; Kelemen, Pond; Dooley, William C.; Rock, David T.; Cowan, Ken H.; Lesnikoski, Beth-Ann; Barone, Julie L.; Ashikari, Andrew Y.; Dupree, Beth; Wang, Shiyu; Menicucci, Andrea R.; Yoder, Erin B.; Finn, Christine; Corcoran, Kate; Blumencranz, Lisa E.; Audeh, William; ; (Annals of surgical oncology, v.29, 2022, pp.4153-4154)
-
88
- Distinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature
- Whitworth, Pat W.; Beitsch, Peter D.; Pellicane, James V.; Baron, Paul L.; Lee, Laura A.; Dul, Carrie L.; Murray, Mary K.; Gittleman, Mark A.; Budway, Raye J.; Rahman, Rakhshanda Layeequr; Kelemen, Pond R.; Dooley, William C.; Rock, David T.; Cowan, Kenneth H.; Lesnikoski, Beth-Ann; Barone, Julie L.; Ashikari, Andrew Y.; Dupree, Beth B.; Wang, Shiyu; Menicucci, Andrea R.; Yoder, Erin B.; Finn, Christine; Corcoran, Kate; Blumencranz, Lisa E.; Audeh, William; Nashville Breast Center, Nashville, TN; Targeted Medical Education, Cupertino, CA; Bon Secours Cancer Institute, Richmond, VA; Breast and Melanoma Specialist of Charleston, Charleston, SC; Comprehensive Cancer Center, Palm Springs, CA; Ascension St John Hospital Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI; Akron General Medical Center, Akron, OH; Breast Care Specialists, Allentown, PA; St Clair Hospital, Pittsburgh, PA; Texas Tech University, Lubbock, TX; Ashikari Breast Center, Sleepy Hollow, NY; Breast Institute, University of Oklahoma Health Sciences, Oklahoma City, OK; Regional Breast Care, Fort Myers, FL; Fred and Pamela Buffet Cancer Center and Eppley Institute for Research in Cancer at University of Nebraska Medical Center, Omaha, NE; The Breast Institute at JFK Medical Center, Atlantis, FL; Exempla Saint Joseph Hospital, Denver, CO; Zucker School of Medicine, Hofstra University, Hempstead, NY; St Mary Medical Alliance Cancer Specialists,; (Jco precision oncology, v.6, 2022, pp.e2100463)
-
89
- SRSF1-dependent nuclear export inhibition of <i>C9ORF72</i> repeat transcripts prevents neurodegeneration and associated motor deficits
-
Hautbergue, Guillaume M.;
Castelli, Lydia M.;
Ferraiuolo, Laura;
Sanchez-Martinez, Alvaro;
Cooper-Knock, Johnathan;
Higginbottom, Adrian;
Lin, Ya-Hui;
Bauer, Claudia S.;
Dodd, Jennifer E.;
Myszczynska, Monika A.;
Alam, Sarah M.;
Garneret, Pierre;
Chandran, Jayanth S.;
Karyka, Evangelia;
Stopford, Matthew J.;
Smith, Emma F.;
Kirby, Janine;
Meyer, Kathrin;
Kaspar, Brian K.;
Isaacs, Adrian M.;
El-Khamisy, Sherif F.;
De Vos, Kurt J.;
Ning, Ke;
Azzouz, Mimoun;
Whitworth, Alexander J.;
Shaw, Pamela J.;
Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield;
Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield;
Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield;
MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus;
Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield;
Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield;
Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield;
Sheffield Institute for Translational Neuroscience, Department of Neuroscience, University of Sheffield
UK; (Nature communications, v.8, 2017, pp.16063)
-
90
- Age-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
- Whitworth, Pat; Beitsch, Peter D.; Pellicane, James V.; Baron, Paul L.; Lee, Laura A.; Dul, Carrie L.; Nash III, Charles H.; Murray, Mary K.; Richards, Paul D.; Gittleman, Mark; Budway, Raye; Rahman, Rakhshanda Layeequr; Kelemen, Pond; Dooley, William C.; Rock, David T.; Cowan, Ken; Lesnikoski, Beth-Ann; Barone, Julie L.; Ashikari, Andrew Y.; Dupree, Beth; Wang, Shiyu; Menicucci, Andrea R.; Yoder, Erin B.; Finn, Christine; Corcoran, Kate; Blumencranz, Lisa E.; Audeh, William; Nashville Breast Center, Nashville, TN USA; Targeted Medical Education, Cupertino, CA USA; Bon Secours Cancer Institute, Richmond, VA USA; Breast and Melanoma Specialist of Charleston, Charleston, SC USA; Comprehensive Cancer Center, Palm Springs, CA USA; Ascension St. John Hospital Great Lakes Cancer Management Specialists, Grosse Pointe Woods, MI USA; Northeast Georgia Medical Center, Gainesville, GA USA; Akron General Medical Center, Akron, OH USA; Blue Ridge Cancer Center, Roanoke, VA USA; Breast Care Specialists, Allentown, PA USA; St. Clair Hospital, Pittsburgh, PA USA; Texas Tech University, Lubbock, TX USA; Ashikari Breast Center, Sleepy Hollow, NY USA; Breast Institute, University of Oklahoma Health Sciences, Oklahoma City, OK USA; Regional Breast Care, Fort Myers, FL USA; University of Nebraska Medical Center, Omaha, NE USA; The Breast Institute at JFK Medical Center, Atlantis, FL USA; Exempla Saint Joseph Hospital, Denver, CO USA; Ashikari Breast Center, Sl; (Annals of surgical oncology, v.29, 2022, pp.4141-4152)
QUICK MENU
